| Status | Study |
| Active, not recruiting |
Study Name: Mendelian Reverse Cholesterol Transport Study Condition: Cholesterol, HDL Lipid Metabolism, Inborn Errors Tangier D Date: 2013-01-30 Interventions: Drug: 3H-cholesterol bound to albumin up to 100 uCi of [3H]-cholesterol (containing approximately 0.2 mg |
| Completed |
Study Name: Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease Condition: Coronary Artery Disease Atherosclerosis Date: 2012-03-13 Interventions: Drug: ACP-501 A single dose infusion |